Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/54190
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPhitsinee Thipubonen_US
dc.contributor.authorWachiraporn Tipsuwanen_US
dc.contributor.authorChairat Uthaipibullen_US
dc.contributor.authorSineenart Santitherakulen_US
dc.contributor.authorSomdet Srichairatanakoolen_US
dc.date.accessioned2018-09-04T10:09:14Z-
dc.date.available2018-09-04T10:09:14Z-
dc.date.issued2015-01-01en_US
dc.identifier.issn22211691en_US
dc.identifier.other2-s2.0-84952874492en_US
dc.identifier.other10.1016/j.apjtb.2015.07.021en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84952874492&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/54190-
dc.description.abstract© 2015 Hainan Medical University. Objective: To examine the efficacy of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) iron chelator and green tea extract (GTE) as anti-malarial activity in Plasmodium berghei ( P. berghei) infected mice. Methods: The CM1 (0-100 mg/kg/day) and GTE (0-100 mg (-)-epigallocatechin 3-gallate equivalent/kg/day) were orally administered to P. berghei infected mice for consecutive 4 days. Parasitized red blood cells (PRBC) were enumerated by using Giemsa staining microscopic method. Results: CM1 lowered percentage of PRBC in dose-dependent manner with an ED50value of 56.91 mg/kg, when compared with pyrimethamine (PYR) (ED50= 0.76 mg/kg). GTE treatment did not show any inhibition of the malaria parasite growth. In combined treatment, CM1 along with 0.6 mg/kg PYR significantly inhibited the growth of P. berghei in mice while GTE did not enhance the PYR anti-malarial activity. Conclusions: CM1 would be effective per se and synergize with PYR in inhibiting growth of murine malaria parasites, possibly by limiting iron supply from plasma transferrin and host PRBC cytoplasm, and chelating catalytic iron cstitutive in parasites' mitochondrial cytochromes and cytoplasmic ribonucleotide reductase. CM1 would be a promising adjuvant to enhance PYR anti-malarial activity and minimize the drug resistance.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleAnti-malarial effect of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one and green tea extract on erythrocyte-stage Plasmodium berghei in miceen_US
dc.typeJournalen_US
article.title.sourcetitleAsian Pacific Journal of Tropical Biomedicineen_US
article.volume5en_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsUniversity of Phayaoen_US
article.stream.affiliationsThailand National Center for Genetic Engineering and Biotechnologyen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.